Jiang Nan Cai
Director/Board Member chez NANJING VAZYME BIOTECH CO.,LTD
Profil
Jiang Nan Cai is currently an Independent Non-Executive Director at MicuRx Pharmaceuticals, Inc., Independent Director at Betta Pharmaceuticals Co., Ltd., Independent Non-Executive Director at Shanghai NewMed Medical Co., Ltd., and Independent Director at Nanjing Vazyme Biotech Co., Ltd.
Previously, he held positions as an Independent Non-Executive Director at Shanghai Pharmaceuticals Holding Co., Ltd., Independent Non-Executive Director at WuXi AppTec Co., Ltd., Independent Director at Dian Diagnostics Group Co. Ltd., and Independent Non-Executive Director at Harmonicare Medical Holdings Ltd.
He was also the Director of the Health Management & Policy Center at China Europe International Business School and the Head of the Public Economics Department at Fudan University.
Additionally, he served as the Director of the Institute of Economic Development at East China University of Science & Technology.
Dr. Cai holds a doctorate degree from Brandeis University, a graduate degree from Fudan University, and an undergraduate degree from East China Normal University.
Currently, Dr. Cai's current job(s) are Independent Non-Executive Director at MicuRx Pharmaceuticals, Inc., Independent Director at Betta Pharmaceuticals Co., Ltd., Independent Non-Executive Director at Shanghai NewMed Medical Co., Ltd., and Independent Director at Nanjing Vazyme Biotech Co., Ltd.
Postes actifs de Jiang Nan Cai
Sociétés | Poste | Début |
---|---|---|
NANJING VAZYME BIOTECH CO.,LTD | Director/Board Member | 28/05/2020 |
BETTA PHARMACEUTICALS CO., LTD. | Director/Board Member | 22/11/2019 |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Director/Board Member | - |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Director/Board Member | 01/07/2021 |
Anciens postes connus de Jiang Nan Cai
Sociétés | Poste | Fin |
---|---|---|
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Director/Board Member | 29/06/2023 |
WUXI APPTEC CO., LTD. | Director/Board Member | 31/05/2023 |
HARMONICARE MEDICAL HOLDINGS LIMITED | Director/Board Member | 08/02/2021 |
DIAN DIAGNOSTICS GROUP CO.,LTD. | Director/Board Member | 01/09/2020 |
China Europe International Business School | Corporate Officer/Principal | 01/12/2019 |
Formation de Jiang Nan Cai
Brandeis University | Doctorate Degree |
Fudan University | Graduate Degree |
East China Normal University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
DIAN DIAGNOSTICS GROUP CO.,LTD. | Health Services |
NANJING VAZYME BIOTECH CO.,LTD | Health Technology |
Entreprise privées | 3 |
---|---|
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
Harmonicare Medical Holdings Ltd.
Harmonicare Medical Holdings Ltd. Hospital/Nursing ManagementHealth Services Harmonicare Medical Holdings Ltd. engages in medical investments, hospital management and medical brand operating fields. It operates through the following segments: Provision of Hospital Service and Supply of Pharmaceuticals and Medical Devices. The Provision of Hospital Service segment offers obstetrics, gynecology services, and other healthcare services. The Supply of Pharmaceuticals and Medical Devices Business segment supplies pharmaceuticals and medical devices to hospitals. The company was founded by Yu Ming Lin on August 26, 2014 and is headquartered in Beijing, China. | Health Services |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Health Technology |